Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Cash & Current Investments (2013 - 2025)

Enlivex (ENLV) posted quarterly Cash & Current Investments of $5.8 million for Q4 2025, down 75.51% year-over-year from $23.5 million in Q4 2024, and up 130.0% quarter-over-quarter from -$19.2 million in Q3 2025.

Enlivex (ENLV) Cash & Current Investments (2013 - 2025) Analysis & Trends

Enlivex's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $5.8 million for Q4 2025.

  • In Q4 2025, Cash & Current Investments fell 75.51% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (down 75.51% YoY), while the FY2025 annual figure was $5.8 million, up 119.8% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $5.8 million, up from -$19.2 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $78.0 million in Q1 2022, with the low at -$30.8 million in Q2 2023.
  • The 5-year median for Cash & Current Investments is $22.8 million (2021), against an average of $22.4 million.
  • Peak annual rise in Cash & Current Investments reached 378.43% in 2023, while the deepest fall reached 149.04% in 2023.
  • Enlivex's Cash & Current Investments stood at $69.9 million in 2021, then plunged by 83.79% to $11.3 million in 2022, then soared by 378.43% to $54.2 million in 2023, then tumbled by 56.68% to $23.5 million in 2024, then sank by 75.51% to $5.8 million in 2025.
  • Business Quant data shows ENLV's Cash & Current Investments at $5.8 million in Q4 2025, -$19.2 million in Q3 2025, and $19.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Enlivex 4.51 Mn -1.25 Mn - 5.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.76 Mn
Sep 30, 2025 -19.19 Mn
Jun 30, 2025 19.51 Mn
Mar 31, 2025 20.55 Mn
Dec 31, 2024 23.50 Mn
Sep 30, 2024 -28.45 Mn
Jun 30, 2024 25.94 Mn
Mar 31, 2024 23.44 Mn
Dec 31, 2023 54.24 Mn
Sep 30, 2023 -28.27 Mn
Jun 30, 2023 -30.76 Mn
Mar 31, 2023 -18.05 Mn
Dec 31, 2022 11.34 Mn
Sep 30, 2022 57.66 Mn
Jun 30, 2022 62.88 Mn
Mar 31, 2022 78.00 Mn
Dec 31, 2021 69.94 Mn
Sep 30, 2021 22.15 Mn
Jun 30, 2021 23.61 Mn
Mar 31, 2021 73.23 Mn